Skip to content
LexBuild

Advisory Committee for Innovation Corps; Notice of Meeting

---
identifier: "/us/fr/2013-03163"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Advisory Committee for Innovation Corps; Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2013-03163"
section_name: "Advisory Committee for Innovation Corps; Notice of Meeting"
positive_law: false
currency: "2013-02-12"
last_updated: "2013-02-12"
format_version: "1.1.0"
generator: "[email protected]"
agency: "National Science Foundation"
document_number: "2013-03163"
document_type: "notice"
publication_date: "2013-02-12"
agencies:
  - "National Science Foundation"
fr_citation: "78 FR 9945"
fr_volume: 78
---

#  Advisory Committee for Innovation Corps; Notice of Meeting

In accordance with the Federal Advisory Committee Act (Pub., L.92-463, as amended), the National Science Foundation announces the following meeting:

*Name:* Innovation Corps Advisory Committee, #80463

*Dates/Time:* March 6, 2013, 9:00 a.m.-4:00 p.m.

*Places:* Sheraton Pentagon City Hotel, 900 South Orme Street, Arlington, VA 22204

*Type of Meeting:* Open

*Contact Person:* Dr. Dedric A. Carter, Senior Advisor for Strategic Initiatives, Office of the Director, Suite 1205, National Science Foundation, 4201 Wilson Boulevard, Arlington, VA 22230 Telephone Number: (703) 292-8002 *[email protected]*

*Purpose of Meeting:* To provide advice and recommendations concerning I-Corps.

*Agenda:* Opening Statements by Dr. Subra Suresh, Director, NSF Review and discussion the current I-Corps projects and future directions.

*Reason for Closing:* The program being reviewed includes information of a proprietary or confidential nature, including technical information; financial data, such as salaries; and personal information concerning individuals associated with the proposals. These matters are exempt under (4) and (6) of 5 U.S.C. 552b(c), the Government in the Sunshine Act.

Dated: February 7, 2013.

Susanne Bolton,

Committee Management Officer.